Sandborn WJ - Search Results

1

Ordás I, Eckmann L, Talamini M, Baumgart DC, Sandborn WJ. Ordás I, et al. Among authors: sandborn wj. Lancet. 2012 Nov 3;380(9853):1606-19. doi: 10.1016/S0140-6736(12)60150-0. Epub 2012 Aug 20. Lancet. 2012. PMID: 22914296 Free article. Review.

2

Ulcerative colitis disease activity following treatment of associated primary sclerosing cholangitis with cyclosporin.

Sandborn WJ, Wiesner RH, Tremaine WJ, Larusso NF. Sandborn WJ, et al. Gut. 1993 Feb;34(2):242-6. doi: 10.1136/gut.34.2.242. Gut. 1993. PMID: 8432481 Free PMC article. Clinical Trial.

3

Nicotine therapy for ulcerative colitis: a review of rationale, mechanisms, pharmacology, and clinical results.

Sandborn WJ. Sandborn WJ. Am J Gastroenterol. 1999 May;94(5):1161-71. doi: 10.1111/j.1572-0241.1999.01059.x. Am J Gastroenterol. 1999. PMID: 10235187 Review.

4

Intravenous azathioprine in severe ulcerative colitis: a pilot study.

Mahadevan U, Tremaine WJ, Johnson T, Pike MG, Mays DC, Lipsky JJ, Sandborn WJ. Mahadevan U, et al. Among authors: sandborn wj. Am J Gastroenterol. 2000 Dec;95(12):3463-8. doi: 10.1111/j.1572-0241.2000.03362.x. Am J Gastroenterol. 2000. PMID: 11151878 Clinical Trial.

5

Microscopic colitis: a review.

Pardi DS, Smyrk TC, Tremaine WJ, Sandborn WJ. Pardi DS, et al. Among authors: sandborn wj. Am J Gastroenterol. 2002 Apr;97(4):794-802. doi: 10.1111/j.1572-0241.2002.05595.x. Am J Gastroenterol. 2002. PMID: 12003412 Review.

6

The fate of low grade dysplasia in ulcerative colitis.

Ullman TA, Loftus EV Jr, Kakar S, Burgart LJ, Sandborn WJ, Tremaine WJ. Ullman TA, et al. Among authors: sandborn wj. Am J Gastroenterol. 2002 Apr;97(4):922-7. doi: 10.1111/j.1572-0241.2002.05610.x. Am J Gastroenterol. 2002. PMID: 12008669

7

N-acetyltransferase 1 and 2 genotypes do not predict response or toxicity to treatment with mesalamine and sulfasalazine in patients with ulcerative colitis.

Ricart E, Taylor WR, Loftus EV, O'Kane D, Weinshilboum RM, Tremaine WJ, Harmsen WS, Zinsmeister AR, Sandborn WJ. Ricart E, et al. Among authors: sandborn wj. Am J Gastroenterol. 2002 Jul;97(7):1763-8. doi: 10.1111/j.1572-0241.2002.05838.x. Am J Gastroenterol. 2002. PMID: 12135032

8

Azathioprine or 6-mercaptopurine before colectomy for ulcerative colitis is not associated with increased postoperative complications.

Mahadevan U, Loftus EV Jr, Tremaine WJ, Pemberton JH, Harmsen WS, Schleck CD, Zinsmeister AR, Sandborn WJ. Mahadevan U, et al. Among authors: sandborn wj. Inflamm Bowel Dis. 2002 Sep;8(5):311-6. doi: 10.1097/00054725-200209000-00001. Inflamm Bowel Dis. 2002. PMID: 12479645

9

Systematic review: the pharmacokinetic profiles of oral mesalazine formulations and mesalazine pro-drugs used in the management of ulcerative colitis.

Sandborn WJ, Hanauer SB. Sandborn WJ, et al. Aliment Pharmacol Ther. 2003 Jan;17(1):29-42. doi: 10.1046/j.1365-2036.2003.01408.x. Aliment Pharmacol Ther. 2003. PMID: 12492730 Free article. Review.

10

Delayed-release oral mesalamine at 4.8 g/day (800 mg tablet) for the treatment of moderately active ulcerative colitis: the ASCEND II trial.

Hanauer SB, Sandborn WJ, Kornbluth A, Katz S, Safdi M, Woogen S, Regalli G, Yeh C, Smith-Hall N, Ajayi F. Hanauer SB, et al. Among authors: sandborn wj. Am J Gastroenterol. 2005 Nov;100(11):2478-85. doi: 10.1111/j.1572-0241.2005.00248.x. Am J Gastroenterol. 2005. PMID: 16279903 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

947 results

Search Page